Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,484
Total Claims
$904K
Drug Cost
1,065
Beneficiaries
$849
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-96%
Opioid rate vs peers
0.1% vs 2.6% avg
-20%
Cost per patient vs peers
$849 vs $1,068 avg
+10%
Brand preference vs peers
9.9% vs 9.0% avg
Opioid Prescribing
0.1%
Opioid Rate
13
Opioid Claims
$46
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,129 claims · $669K
Generic: 10,229 claims · $221K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 106 | $111K |
| Rivaroxaban | 71 | $57K |
| Sitagliptin Phosphate | 60 | $48K |
| Fluticasone/Umeclidin/Vilanter | 50 | $40K |
| Semaglutide | 24 | $40K |
| Empagliflozin | 26 | $28K |
| Dapagliflozin Propanediol | 25 | $24K |
| Insulin Glargine,hum.Rec.Anlog | 37 | $24K |
| Tiotropium Bromide | 14 | $14K |
| Umeclidinium Brm/Vilanterol Tr | 15 | $14K |
| Sitagliptin Phos/Metformin Hcl | 17 | $13K |
| Linagliptin | 13 | $13K |
| Insulin Glargine,hum.Rec.Anlog | 16 | $13K |
| Evolocumab | 11 | $10K |
| Atorvastatin Calcium | 674 | $8,917 |
Prescribing Profile
Patient Profile
74
Avg Age
47%
Female
1.04
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data